Clinical cancer advances 2020: annual report on progress against cancer from the American Society of Clinical Oncology
MJ Markham, K Wachter, N Agarwal… - Journal of Clinical …, 2020 - ascopubs.org
Each year Clinical Cancer Advances: ASCO's Annual Report on Progress Against Cancer
highlights the most important clinical research advances of the past year, including the …
highlights the most important clinical research advances of the past year, including the …
Kidney cancer: an overview of current therapeutic approaches
N Chowdhury, CG Drake - Urologic Clinics, 2020 - urologic.theclinics.com
Worldwide, approximately 400,000 individuals were diagnosed with renal cell carcinoma
(RCC) in 2018; that is, it is fairly common. In the United States, RCC is among the top 10 …
(RCC) in 2018; that is, it is fairly common. In the United States, RCC is among the top 10 …
Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: an analysis of the National Cancer …
N Singla, RC Hutchinson, RA Ghandour… - … Oncology: Seminars and …, 2020 - Elsevier
Objectives Despite immune checkpoint inhibitor (ICI) approval for metastatic renal cell
carcinoma (mRCC) in 2015, cytoreductive nephrectomy (CN) is guided by extrapolation from …
carcinoma (mRCC) in 2015, cytoreductive nephrectomy (CN) is guided by extrapolation from …
Systematic review of the role of cytoreductive nephrectomy in the targeted therapy era and beyond: an individualized approach to metastatic renal cell carcinoma
B Bhindi, EJ Abel, L Albiges, K Bensalah, SA Boorjian… - European urology, 2019 - Elsevier
Context The role of cytoreductive nephrectomy (CN) in the management of metastatic renal
cell carcinoma (mRCC) in the targeted therapy (TT) era is controversial. Objective To assess …
cell carcinoma (mRCC) in the targeted therapy (TT) era is controversial. Objective To assess …
[图书][B] Encyclopedia of gerontology and population aging
D Gu, ME Dupre - 2021 - Springer
Diet is the only known intervention which has been conclusively shown to extend life span. It
can be argued the key role diet has to play in the aging process came to prominence as a …
can be argued the key role diet has to play in the aging process came to prominence as a …
Sunitinib alone or after nephrectomy for patients with metastatic renal cell carcinoma: is there still a role for cytoreductive nephrectomy?
A Méjean, A Ravaud, S Thezenas, C Chevreau… - European Urology, 2021 - Elsevier
Background The CARMENA trial in patients with metastatic renal cell carcinoma (mRCC)
demonstrated that treatment with sunitinib alone was noninferior to cytoreductive …
demonstrated that treatment with sunitinib alone was noninferior to cytoreductive …
Treatment selection in first-line metastatic renal cell carcinoma—the contemporary treatment paradigm in the age of combination therapy: a review
Importance The treatment landscape of metastatic renal cell carcinoma has evolved rapidly
over the last decade. Recent combination approaches heralded by targeting immune …
over the last decade. Recent combination approaches heralded by targeting immune …
[HTML][HTML] Comprehensive review of chromophobe renal cell carcinoma
Chromophobe renal cell carcinoma (chRCC) is the third most common type of RCC with
distinct biology compared to other kidney cancer subtypes. The heterogeneity between the …
distinct biology compared to other kidney cancer subtypes. The heterogeneity between the …
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma
E Hasanov, DN Yeboa, MD Tucker… - CA: A Cancer …, 2022 - Wiley Online Library
Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited
understanding of brain metastasis tumor and immune biology, drivers of resistance to …
understanding of brain metastasis tumor and immune biology, drivers of resistance to …
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial
Background Pheochromocytoma (PCC) and paraganglioma (PGL) are uncommon
neoplasms with high morbidity in advanced stages. Effective systemic treatments are limited …
neoplasms with high morbidity in advanced stages. Effective systemic treatments are limited …